Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
JPMORGAN CHASE & CO | 02-12-2024 | 12-31-2023 | 30972 | 1,040,788,602,081 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
ONCOLYTICS BIOTECH INC | COMMON | 10801 | $15,525 | 11,500 | 0.00 | 11,500 | +Inf | 12-31-2023 | |
Robert Half Inc | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -1 | -0.48 | 12-31-2023 |
FIRST TRUST NASDAQ SEMICONDU | FUND | Liquidated | $0 | 0 | 0.00 | 218 | +Inf | 12-31-2023 | |
Jabil Inc | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | 22 | 18.18 | 12-31-2023 |